Eli Lilly is reportedly in advanced talks to buy Boston‑based Kelonia Therapeutics for more than $2 billion, folding a promising in‑vivo CAR‑T program into Lilly’s pipeline.

Franciscan Alliance is moving to build an osteopathic medical school in Crown Point, with leadership roles posted and campus work already under way.

A federal appeals court revived Teva’s patent fight with Eli Lilly and sent the case back to Massachusetts, reopening a dispute that once produced a $176.5M jury award.

Indiana University physicians were co‑authors on a NEJM trial showing enfortumab vedotin plus pembrolizumab produced large survival gains for certain bladder cancer patients. IU sites helped enroll and analyze the data behind the finding.

Gov. Mike Braun toured Ossium Health’s Indianapolis bone‑marrow bank as the state spotlights a $1 billion life‑sciences growth plan.

Eric Christopher, the co-founder of Zylo, will take over as TechPoint’s president and CEO on April 7, stepping into a statewide role focused on talent, capital and AI. The hire follows a national search and the departure of Ting Gootee to CICP.

A Lumina–Gallup study finds 47% of students have seriously considered changing majors because of AI, while 57% use AI weekly and many campus policies remain unclear.

Eli Lilly will buy Boston‑based Centessa for about $6.3B, adding an orexin agonist program led by cleminorexton. The deal pays $38 per ADS up front and could reach $47 with milestones.

Indianapolis‑based Eli Lilly says retatrutide met a Phase‑3 diabetes endpoint with notable A1c and double‑digit weight drops at 40 weeks, while more safety and regulatory steps remain.

Gov. Mike Braun announced a $1 billion pledge to expand central Indiana’s life‑sciences and ag ecosystem, saying it could support as many as 100,000 jobs.

Sen. Todd Young says Indiana's new federal drone test‑site designation has manufacturers lining up to test tech and could spur manufacturing and biomanufacturing jobs.

IU researchers show that sampling the right water pools removes puzzling isotope mismatches and could sharpen drought and water‑use forecasts for crops and ecosystems.

Indiana Donor Network used an in‑house ex‑vivo lung perfusion system to rehabilitate lungs rejected elsewhere, enabling a transplant that saved a local man.